Since the publication of this paper, the authors have noted that there was an error in Figure 1d , in that, the GAPDH for combination treatment with CA-4 and CQ in SJSA cells by mistake duplicated for CQ alone treatment (Figure 3e ). This error has now been rectified. The correct figure is shown below.
The authors would like to apologize for any inconvenience this may have caused. ) were quantified, and the LC3-II/GAPDH and SQSTM1/GAPDH ratios were calculated and displayed. (d) SJSA and MG63.2 cells were treated with CA-4 in the presence or absence of CQ, and the whole-cell lysates were subjected to immunoblotting of LC3B-II, SQSTM1 and GAPDH. (e and f) The protein bands in (d) were quantified, and the LC3-II/GAPDH and SQSTM1/GAPDH ratios were calculated. (g) SJSA and MG63.2 cells expressing GFP-LC3 were treated with control, CA-4 and CQ, and the GFP-LC3 puncta were observed under confocal microscopy. (h) Quantification of the number of GFP-LC3 puncta per cell in (g). The data were presented as mean ± SD (*P ⩽ 0.05, n = 3) Citation: Cell Death and Disease (2017) 8, e3131; doi:10.1038 /cddis.2017 Macmillan Publishers Limited, part of Springer Nature.
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